Literature DB >> 19661482

Foxp3 regulates megakaryopoiesis and platelet function.

Jamie J Bernard1, Kathryn E Seweryniak, Anne D Koniski, Sherry L Spinelli, Neil Blumberg, Charles W Francis, Mark B Taubman, James Palis, Richard P Phipps.   

Abstract

OBJECTIVE: Platelets are crucial for hemostasis and are vital regulators of inflammation. Foxp3 is a key transcription factor for T regulatory cell development. Humans with IPEX (immune dysregulation, polyendocrinopathy, enteropathy, x-linked) and the scurfy (Foxp3(sf)) mouse have mutations in the Foxp3 gene that lead to a host of pathologies including autoimmunity and skin diseases. Scurfy mice and some humans with IPEX are also thrombocytopenic. The purpose of this study was to determine whether the absence of functional Foxp3 leads to defects in megakaryocytes and platelets. METHODS AND
RESULTS: We discovered that human and mouse megakaryocytes express Foxp3 mRNA and protein. Using shRNA and Foxp3(sf) mice, we demonstrated that Foxp3-deficient mouse and human megakaryocyte progenitors exhibited proliferation defects. Striking platelet abnormalities were observed in both an IPEX patient and Foxp3(sf) mice. Impaired platelet spreading and release of TGF-beta and CD40 ligand (CD40L), and abnormal levels of plasma CD40L were observed in a case of IPEX syndrome. Foxp3(sf) mice were thrombocytopenic and had increased platelet volume and altered serum levels of CD40L, TXB(2), and TGF-beta.
CONCLUSIONS: These findings provide compelling new evidence that Foxp3 is needed for proper megakaryopoiesis and plays a role in regulating platelet function including spreading and release.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19661482      PMCID: PMC3017715          DOI: 10.1161/ATVBAHA.109.193805

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  53 in total

1.  Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.

Authors:  Masahiro Ono; Hiroko Yaguchi; Naganari Ohkura; Issay Kitabayashi; Yuko Nagamura; Takashi Nomura; Yoshiki Miyachi; Toshihiko Tsukada; Shimon Sakaguchi
Journal:  Nature       Date:  2007-03-21       Impact factor: 49.962

Review 2.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

3.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

4.  Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer.

Authors:  Sebastian Hinz; Laia Pagerols-Raluy; Hans-Heinrich Oberg; Ole Ammerpohl; Sandra Grüssel; Bence Sipos; Robert Grützmann; Christian Pilarsky; Hendrik Ungefroren; Hans-Detlev Saeger; Günter Klöppel; Dieter Kabelitz; Holger Kalthoff
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

5.  Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor.

Authors:  B Savage; E Saldívar; Z M Ruggeri
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

Review 6.  FOXP3 actively represses transcription by recruiting the HAT/HDAC complex.

Authors:  Bin Li; Mark I Greene
Journal:  Cell Cycle       Date:  2007-05-10       Impact factor: 4.534

7.  Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of beta-thromboglobulin and platelet factor 4.

Authors:  Risa Tamagawa-Mineoka; Norito Katoh; Eiichiro Ueda; Koji Masuda; Saburo Kishimoto
Journal:  Allergol Int       Date:  2008-12-01       Impact factor: 5.836

8.  Cutting edge: Broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells.

Authors:  Guo-Yun Chen; Chong Chen; Lizhong Wang; Xing Chang; Pan Zheng; Yang Liu
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

9.  A novel cadherin cell adhesion molecule: its expression patterns associated with implantation and organogenesis of mouse embryos.

Authors:  A Nose; M Takeichi
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

10.  Foxp3 expression in human cancer cells.

Authors:  Vaios Karanikas; Matthaios Speletas; Maria Zamanakou; Fani Kalala; Gedeon Loules; Theodora Kerenidi; Angeliki K Barda; Konstantinos I Gourgoulianis; Anastasios E Germenis
Journal:  J Transl Med       Date:  2008-04-22       Impact factor: 5.531

View more
  6 in total

1.  Characterization of human invariant natural killer T cells expressing FoxP3.

Authors:  Péter Engelmann; Klára Farkas; János Kis; Geoffrey Richman; Zhaoyun Zhang; Chong Wee Liew; Maciej Borowiec; Monika A Niewczas; Heyam Jalahej; Tihamér Orbán
Journal:  Int Immunol       Date:  2011-06-27       Impact factor: 4.823

2.  High-Throughput Production of Platelet-Like Particles.

Authors:  Kylie M Persson; Pauline V Kneller; Mark W Livingston; Lucas M Bush; Tara L Deans
Journal:  Methods Mol Biol       Date:  2021

3.  FOXP3 and GARP (LRRC32): the master and its minion.

Authors:  Michael Probst-Kepper; Jan Buer
Journal:  Biol Direct       Date:  2010-02-05       Impact factor: 4.540

4.  Platelet defects in congenital variant of Rett syndrome patients with FOXG1 mutations or reduced expression due to a position effect at 14q12.

Authors:  Christophe Goubau; Koen Devriendt; Nathalie Van der Aa; An Crepel; Dagmar Wieczorek; Tjitske Kleefstra; Marjolein H Willemsen; Anita Rauch; Andreas Tzschach; Thomy de Ravel; Peter Leemans; Chris Van Geet; Gunnar Buyse; Kathleen Freson
Journal:  Eur J Hum Genet       Date:  2013-05-01       Impact factor: 4.246

5.  Severe Developmental B Lymphopoietic Defects in Foxp3-Deficient Mice are Refractory to Adoptive Regulatory T Cell Therapy.

Authors:  Julia Riewaldt; Sandra Düber; Marie Boernert; Martina Krey; Marcin Dembinski; Siegfried Weiss; Annette I Garbe; Karsten Kretschmer
Journal:  Front Immunol       Date:  2012-06-05       Impact factor: 7.561

Review 6.  Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer.

Authors:  Alessandra Metelli; Mohammad Salem; Caroline H Wallace; Bill X Wu; Anqi Li; Xue Li; Zihai Li
Journal:  J Hematol Oncol       Date:  2018-02-20       Impact factor: 17.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.